Cargando…
Immunotherapy for Breast Cancer Treatment
Breast cancer, as a heterogeneous disease, includes a wide range of pathological and clinical behaviors. Current treatment protocols, including radiotherapy, chemotherapy, and hormone replacement therapy, are mainly associated with poor response and high rate of recurrence. Therefore, more efforts a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pasteur Institute of Iran
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183391/ https://www.ncbi.nlm.nih.gov/pubmed/33724757 http://dx.doi.org/10.52547/ibj.25.3.140 |
_version_ | 1783704369922834432 |
---|---|
author | Simonian, Miganoosh Haji Ghaffari, Mozhan Negahdari, Babak |
author_facet | Simonian, Miganoosh Haji Ghaffari, Mozhan Negahdari, Babak |
author_sort | Simonian, Miganoosh |
collection | PubMed |
description | Breast cancer, as a heterogeneous disease, includes a wide range of pathological and clinical behaviors. Current treatment protocols, including radiotherapy, chemotherapy, and hormone replacement therapy, are mainly associated with poor response and high rate of recurrence. Therefore, more efforts are needed to develop alternative therapies for this type of cancer. Immunotherapy, as a novel strategy in cancer treatment, has a potential in treating breast cancer patients. Although breast cancer has long been considered problematic to treat with immunotherapy, as it is immunologically "cold," numerous newer preclinical and clinical reports now recommend that immunotherapy has the capability to treat breast cancer patients. In this review, we highlight the different immunotherapy strategies in breast cancer treatment. |
format | Online Article Text |
id | pubmed-8183391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Pasteur Institute of Iran |
record_format | MEDLINE/PubMed |
spelling | pubmed-81833912021-06-11 Immunotherapy for Breast Cancer Treatment Simonian, Miganoosh Haji Ghaffari, Mozhan Negahdari, Babak Iran Biomed J Review Article Breast cancer, as a heterogeneous disease, includes a wide range of pathological and clinical behaviors. Current treatment protocols, including radiotherapy, chemotherapy, and hormone replacement therapy, are mainly associated with poor response and high rate of recurrence. Therefore, more efforts are needed to develop alternative therapies for this type of cancer. Immunotherapy, as a novel strategy in cancer treatment, has a potential in treating breast cancer patients. Although breast cancer has long been considered problematic to treat with immunotherapy, as it is immunologically "cold," numerous newer preclinical and clinical reports now recommend that immunotherapy has the capability to treat breast cancer patients. In this review, we highlight the different immunotherapy strategies in breast cancer treatment. Pasteur Institute of Iran 2021-05 2021-03-08 /pmc/articles/PMC8183391/ /pubmed/33724757 http://dx.doi.org/10.52547/ibj.25.3.140 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Simonian, Miganoosh Haji Ghaffari, Mozhan Negahdari, Babak Immunotherapy for Breast Cancer Treatment |
title | Immunotherapy for Breast Cancer Treatment |
title_full | Immunotherapy for Breast Cancer Treatment |
title_fullStr | Immunotherapy for Breast Cancer Treatment |
title_full_unstemmed | Immunotherapy for Breast Cancer Treatment |
title_short | Immunotherapy for Breast Cancer Treatment |
title_sort | immunotherapy for breast cancer treatment |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183391/ https://www.ncbi.nlm.nih.gov/pubmed/33724757 http://dx.doi.org/10.52547/ibj.25.3.140 |
work_keys_str_mv | AT simonianmiganoosh immunotherapyforbreastcancertreatment AT hajighaffarimozhan immunotherapyforbreastcancertreatment AT negahdaribabak immunotherapyforbreastcancertreatment |